More than one in eight Australians are not buying personal hygiene products because they cannot afford them, a survey shows.

Anbogen Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application for ABT-3 ...

Contact Email: [email protected] Dates: 6 Aug 2025 to 26 Sep 2025 ...

Specialist support has made a huge difference for one rural child struggling with learning difficulties, yet many lack access to diagnosis and clinical hel ...

Nearly half of young Australians feel lonely, with experts warning digital life, the cost of living and lack of connection are fuelling a growing crisis.

Australian mothers are giving birth at an older age on average, while birth rates have fallen according to a report on health and birth outcomes.

A study has revealed microplastics suspended in the air of cars and homes can penetrate the lungs, increasing the risk of multiple diseases.

As Labor moves to deliver on its pledge to make medicines cheaper for Australians, the prime minister was happy to meet with women who would benefit from i ...

ResMed shares have hit an all-time high after the medical device-maker beat expectations on both revenue and profit.

People who have fully recovered from many cancers can now donate blood and plasma in Australia, 12 months after finishing treatment.

A clinical trial of the drug Trontinemab will aim to delay or prevent the symptoms of Alzheimer's disease, Swiss drugmaker Roche says.

A groundbreaking Australian study is using DNA analysis to pinpoint a person's genetic risk of developing multiple sclerosis.